BlossomHill Therapeutics, Inc. (BLSM) Stock Analysis & Investment Frameworks
BlossomHill Therapeutics, Inc. (BLSM) stock analysis on Invetso. Review BlossomHill Therapeutics, Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
BlossomHill Therapeutics, Inc. Company Overview
- Exchange: NASDAQ
- Sector: Healthcare
- Industry: Biotechnology
- Country: US
BlossomHill Therapeutics, Inc. Key Financial Metrics
- Market Cap: $392.60M
- Revenue: $N/A
- ROE: 127.76%
- ROIC: -43.86%
- Dividend Yield: N/A
About BlossomHill Therapeutics, Inc.
Blossomhill Therapeutics, Inc. is a biopharmaceutical company. It engages in the development of small molecule medicines for unmet medical needs in cancer treatment. The company was founded in June 2020 and is headquartered in San Diego, CA.